Critical appraisal of the current practice in murine TNBS-induced colitis

The immunological and genetic basis of inflammatory bowel disease

2003 • 1,766 citations

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis

2005 • 574 citations

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

2003 • 253 citations

Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production in mice

2001 • 201 citations

Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?

2004 • 187 citations

Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotides

2005 • 169 citations

Mouse models for the study of Crohn's disease

2003 • 165 citations

Induction of <scp>TNBS</scp> Colitis in Mice

2002 • 149 citations

Inhibition of RICK/Nuclear Factor-κB and p38 Signaling Attenuates the Inflammatory Response in a Murine Model of Crohn Disease

2005 • 146 citations

Experimental colitis in mice and sensitization of converging visceral and somatic afferent pathways

2005 • 106 citations

Therapeutic potential of follistatin for colonic inflammation in mice

2005 • 93 citations

Recommendations for Improved Use of the Murine TNBS-Induced Colitis Model in Evaluating Anti-inflammatory Properties of Lactic Acid Bacteria: Technical and Microbiological Aspects

2006 • 86 citations

Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-γ receptor-deficient mice

2000 • 83 citations

Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses

2002 • 76 citations

Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice

2005 • 75 citations

Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis

2005 • 67 citations

cDNA Array Analysis of Cytokines, Chemokines, and Receptors Involved in the Development of TNBS-Induced Colitis: Homeostatic Role of VIP

2005 • 67 citations

Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease

2005 • 58 citations

Systemic administration of the chemokine macrophage inflammatory protein 1 exacerbates inflammatory bowel disease in a mouse model

2005 • 45 citations

Protection against 2,4,6-trinitrobenzenesulphonic acid-induced colonic inflammation in mice by the marine products bolinaquinone and petrosaspongiolide M

2005 • 42 citations

Fumigaclavine C, an fungal metabolite, improves experimental colitis in mice via downregulating Th1 cytokine production and matrix metalloproteinase activity

2005 • 38 citations

Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice

2005 • 36 citations

Therapeutic Effect of the Immunomodulator Glatiramer Acetate on Trinitrobenzene Sulfonic Acid-Induced Experimental Colitis

2005 • 32 citations

Cholera toxin subunit B inhibits IL-12 and IFN- production and signaling in experimental colitis and Crohn's disease

2005 • 30 citations

The Role of the Tumor Necrosis Factor Receptor in 2,4,6-Trinitrobenzene Sulfonic Acid (TNBS)-Induced Colitis in Mice

2005 • 25 citations

Adoptive transfer of NK 1.1+ lymphocytes in immune-mediated colitis: a pro-inflammatory or a tolerizing subgroup of cells?

2005 • 21 citations

Amelioration of experimental colitis by Copaxone is associated with class-II-restricted CD4 immune blocking

2005 • 14 citations

Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice

2005 • 14 citations

Regulatory Role of the Pituitary-Adrenal Axis in Experimental Colitis: Effect of Adrenalectomy on the Clinical Course and the TH1/TH2 Immune Profile

2005 • 13 citations